Literature DB >> 18274564

Oxidative stress in patients with benign prostate hyperplasia.

M Aryal1, A Pandeya, B K Bas, M Lamsal, S Majhi, R Pandit, C S Agrawal, N Gautam, N Baral.   

Abstract

Benign Prostate Hyperplasia (BPH) is a common health problem in aging male. Free radicals and Reactive Oxygen Species (ROS) are produced in overwhelming quantity with advancement of age. When in oxidative stress, these reactive species cause extensive damage to various organ in the body, may be associated with pathogenesis of BPH also. This study aimed at assessing Malondialdehyde (MDA), the marker of lipid peroxidation and anti-oxidants e.g. alpha-Tocopherol and Ascorbate status in plasma in BPH patients. Forty eight (n=48) cases of BPH and forty six (n = 46) healthy age matched controls were enrolled. Plasma MDA level showed 4.81+/-1.87 nmol/ml in cases compared to 3.69+/-1.56 nmol/ml in healthy controls (p<0.001). There were significant decrease in plasma alpha-Tocopherol and ascorbate level which were 0.85+/-0.12 mg/dl and 0.93 +/- 0.13 mg/dl in cases compared to 1.37+/-0.31 mg/dl and 1.44+/-0.38 mg/dl in healthy controls respectively. Inverse correlation of plasma MDA with alpha-Tocopherol (r = -0.09, p>0.05) and Ascorbate (r =-0.51, p=0.008) was found in BPH patients. There was mild elevation of PSA in BPH patients compared with control but was not statistically significant. Thus, our study showed the evidence of association of oxidative stress in BPH patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18274564

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  8 in total

Review 1.  The functional role of reactive stroma in benign prostatic hyperplasia.

Authors:  Isaiah G Schauer; David R Rowley
Journal:  Differentiation       Date:  2011-06-12       Impact factor: 3.880

2.  Peripheral mononuclear leukocyte DNA damage, plasma prolidase activity, and oxidative status in patients with benign prostatic hyperplasia.

Authors:  Ilhan Gecit; Ismail Meral; Mehmet Aslan; Abdurrahim Kocyigit; Hakim Celik; Abdullah Taskın; Mehmet Kaba; Necip Pirincci; Mustafa Gunes; Kerem Taken; Halit Demir; Mehmet Uyuklu; Kadir Ceylan
Journal:  Redox Rep       Date:  2014-12-31       Impact factor: 4.412

Review 3.  The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities.

Authors:  Xun Fu; Huan Liu; Jiang Liu; Michael E DiSanto; Xinhua Zhang
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

4.  The Prostate-Associated Gene 4 (PAGE4) Could Play a Role in the Development of Benign Prostatic Hyperplasia under Oxidative Stress.

Authors:  Yan Li; Jianmin Liu; Daoquan Liu; Zhen Wang; Yongying Zhou; Shu Yang; Feng Guo; Liang Yang; Xinhua Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-05-19       Impact factor: 7.310

5.  Potential of Moringa oleifera in the Treatment of Benign Prostate Hyperplasia: Role of Antioxidant Defence Systems.

Authors:  Ismail O Ishola; Kayode O Yemitan; Olasunmbo O Afolayan; Charles C Anunobi; Tobi E Durojaiye
Journal:  Med Princ Pract       Date:  2017-12-17       Impact factor: 1.927

Review 6.  Oxidative stress in prostate hyperplasia and carcinogenesis.

Authors:  Udensi K Udensi; Paul B Tchounwou
Journal:  J Exp Clin Cancer Res       Date:  2016-09-08

7.  D-004 ameliorates phenylephrine-induced urodynamic changes and increased prostate and bladder oxidative stress in rats.

Authors:  Ambar Oyarzábal; Yohani Pérez; Vivian Molina; Rosa Mas; Yazmin Ravelo; Sonia Jiménez
Journal:  Transl Androl Urol       Date:  2015-08

Review 8.  Oxidative Stress Links Aging-Associated Cardiovascular Diseases and Prostatic Diseases.

Authors:  Ming-Juan Zhao; Shuai Yuan; Hao Zi; Jia-Min Gu; Cheng Fang; Xian-Tao Zeng
Journal:  Oxid Med Cell Longev       Date:  2021-07-17       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.